Sponsor Dossier
Taiho Pharma
Sponsor Dossier for Taiho Pharma. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
About
Taiho Pharma is an Australian Private Company with ABN 97 675 212 530, registered in NSW and currently active.
Portfolio
Taiho Pharma has 2 brands on the ARTG, of which 2 are indexable and 2 carry a Product Information document. 2 brands are PBS-listed, 2 have a PBAC outcome on record, and 1 has an AusPAR on record. Notable brands include INQOVI, LYTGOBI.
Therapeutic focus
— Oncology: 2 brands
PBS footprint
2 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2025-11-01, across 2 brands with a PBAC outcome on record. The latest AusPAR is 2026-03-04, across 1 brand with an AusPAR on record.